Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Australas J Dermatol ; 53(3): e58-60, 2012 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-22881475

RESUMO

Medication-induced dermatomyositis (DM) is rare, but a recent review highlighted hydroxyurea (HU) as the most common inciting agent. To aid diagnosis, HU-induced DM-like eruption (HU DM-LE) forms a distinct dermopathy where the typical cutaneous features of DM are without systemic involvement and co-exist with other HU-induced cutaneous findings such as severe xerosis, atrophy, stomatitis, cutaneous and mucosal ulceration and melanonychia. On cessation of HU the DM-LE clears avoiding unnecessary immunosuppression and demonstrating the importance of consideration of medication aetiology in DM presentations. We present a case report and review of the literature.


Assuntos
Antineoplásicos/efeitos adversos , Dermatomiosite/induzido quimicamente , Toxidermias/etiologia , Hidroxiureia/efeitos adversos , Idoso , Anemia Megaloblástica/induzido quimicamente , Dermatomiosite/patologia , Toxidermias/patologia , Feminino , Humanos , Mielofibrose Primária/tratamento farmacológico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA